Home
Explore services
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
Responsive Menu
Home
Explore services
▼
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
▼
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
▼
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
LOGIN
Research
insights
Impact of first-to-market product on orphan designation status for subsequent products in the EU4
22 January 25
Read More
Named Patient Programs as an access pathway in Germany, France, and the UK
15 January 25
Read More
South Korea Unveils Five-Year Roadmap to Advance AI in Healthcare
13 January 25
Read More
Preparing for Joint Clinical Assessments: To PICO or Not to PICO?
9 January 25
Read More
Pricing and Reimbursement Trends in Europe: Current Landscape and Implications
7 January 25
Read More
Insights into value-based pricing approaches for oncology products in Germany
29 November 24
Read More
Artificial intelligence in pharma access and pricing – will it take over from humans or enhance our understanding?
3 April 24
Read More
Machine Learning for Value-Based Pricing
21 March 24
Read More
Evolving Pharmaceutical Pricing: Dynamic Value-Based Models for Market Success
15 February 24
Read More
The challenge of Healthcare Resource Use (HRU) Data in Low and Middle-Income Countries (LMICs)
6 February 24
Read More
Predicting Price Erosion with Indication Expansion: A Deep Dive
1 February 24
Read More
Harnessing the power of machine learning in market access & pricing
25 January 24
Read More
Unlocking Pharma Dynamics: LoE Impact Analysis
5 January 24
Read More
Predicting value and price of orphan drugs: a comparison across Europe and the US
5 January 24
Read More
Pharmaceutical market access & pricing research: Key trends & industry developments
13 March 23
Read More
How to unlock value for your orphan asset with GPI
15 February 23
Read More
An assessment of the orphan drugs landscape for pharma manufacturers
30 January 23
Read More
The state of international reference pricing in 2023: Canada and South Korea in the spotlight
6 January 23
Read More
GPI demonstrates the strength of forecasting ability across market-specific value frameworks
27 July 22
Read More
Biomarker-targeted therapies: the answer to advancing equitable cancer care?
1 June 22
Read More
“It’s Time For A Prescription Drug Pricing Revolution…”
6 August 21
Read More
Early Pricing and Market Access Forecasting for Orphan Assets
20 May 21
Read More
2025
2024
2023
2022
2021
2020
Stay Informed
Sign up to receive the latest news and trends
straight into your inbox from GPI